-

Guardian Pharmacy Services, Inc. Names Ashley Ragsdale Stockton as Head of Investor Relations

ATLANTA--(BUSINESS WIRE)--Guardian Pharmacy Services, Inc. (“Guardian”) (NYSE: GRDN), one of the nation’s largest and most innovative long-term care (LTC) pharmacy services companies is pleased to announce the appointment of Ashley Stockton as Senior Director, Head of Investor Relations. She will be responsible for leading the investor relations strategy and serving as the primary liaison with shareholders, analysts, and the broader investment community.

Ashley joins Guardian with nearly thirty years of experience in equity markets. Most recently, she served as Head of Southeast Institutional Equity Sales for J.P. Morgan, where she built and managed strategic partnerships with institutional investors, delivering differentiated research insights and strategic access to capital markets.

Earlier in her career, Ashley was an equity research associate across several sectors and held a strategic marketing role in investment banking in New York. Her breadth of experience has equipped her with a strong, multi-dimensional foundation across finance, investor communications, and capital markets.

“We are thrilled to welcome Ashley to Guardian Pharmacy as we continue to grow our investor base,” said Fred Burke, CEO of Guardian Pharmacy Services. “Her extensive background in equity markets and decades of experience advising institutional investors make her an exceptional fit for this role. She has a clear understanding of how to communicate our corporate strategy and will be a powerful voice for Guardian as we continue to expand our footprint and scale.”

“I’m excited to join Guardian Pharmacy at such a pivotal time in its history,” said Stockton. “The company’s commitment to exceptional patient care truly sets it apart, along with its clinical and operational expertise and proven track record of profitable growth. I look forward to sharing Guardian’s compelling story with the broader financial community.”

Stockton holds a Bachelor of Science from the McIntire School of Commerce at the University of Virginia. She currently serves on the board of the Georgia Securities Association.

About Guardian Pharmacy Services

Guardian Pharmacy Services is a leading long-term care pharmacy services company that provides an extensive suite of technology-enabled services designed to help residents of long-term health care facilities (“LTCFs”) adhere to their appropriate drug regimen, which in turn helps reduce the cost of care and improve clinical outcomes. As of December 31, 2024, our 51 pharmacies served approximately 186,000 residents in approximately 7,000 LTCFs across 38 states.

Guardian Pharmacy Services, Inc.

NYSE:GRDN

Release Versions

More News From Guardian Pharmacy Services, Inc.

Guardian Pharmacy Services Announces Pricing of Underwritten Public Offering of Class A Common Stock

ATLANTA--(BUSINESS WIRE)--Guardian Pharmacy Services, Inc. (“Guardian”) (NYSE: GRDN) today announced the pricing of the previously announced underwritten public offering (the “Offering”) of 7,500,000 shares of its Class A common stock, at a public offering price of $21.00 per share, of which 6,059,553 shares will be sold by certain selling stockholders and 1,440,447 shares will be issued and sold by Guardian as part of a non-dilutive “synthetic secondary” transaction, as described below. In add...

Guardian Pharmacy Services Announces Launch of Underwritten Public Offering of Class A Common Stock

ATLANTA--(BUSINESS WIRE)--Guardian Pharmacy Services, Inc. (“Guardian”) (NYSE: GRDN) today announced the launch of a proposed underwritten public offering (the “Offering”) of 7,500,000 shares of its Class A common stock, consisting of 6,059,553 shares being offered by certain selling stockholders and 1,440,447 newly issued shares being offered by Guardian as part of a non-dilutive “synthetic secondary” transaction, as described below. In addition, the selling stockholders intend to grant the un...

Guardian Pharmacy Services, Inc. Reports First Quarter 2025 Financial Results

ATLANTA--(BUSINESS WIRE)--Guardian Pharmacy Services, Inc. (“Guardian”) (NYSE: GRDN), one of the nation’s largest long-term care (LTC) pharmacy services companies, today announced financial results for the first quarter ended March 31, 2025. First Quarter 2025 Highlights Revenue of $329.3 million, an increase of 20% year-over-year, driven by organic growth and the previously announced acquisitions of Heartland Pharmacy on April 1, 2024 and Freedom Pharmacy on November 1, 2024 (the “acquisitions...
Back to Newsroom